CONSTANCE B GORE APN NPI 1235192139

NPI Information

  • NPI: 1235192139
  • Provider Name: CONSTANCE B GORE, APN
  • Classification: Nurse Practitioner - 363LA2100X
  • Specialization: Acute Care
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 100 MADISON AVE
    CAROL G SIMON CANCER CENTER
    MORRISTOWN, NJ
    ZIP 07960
  • Phone: (973) 538-4870

Map and Directions

Get Directions

NPI Details

Constance B Gore, APN is an acute care nurse practitioner in Morristown, NJ with 28 years of experience. Constance B Gore, APN NPI is 1235192139. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1998

The provider's business location address is:

100 MADISON AVE
CAROL G SIMON CANCER CENTER
MORRISTOWN, NJ
ZIP 07960-136
Phone: (973) 538-4870
Fax: (973) 267-6880

The NPI 1235192139 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
  • Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Unclassified drugs (HCPCS:J3490)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)

The enumeration date for this NPI number is 4/11/2006 and was last updated on 9/26/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1363LA2100XNurse PractitionerAcute Care26NN05253500NEW JERSEYYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
10021733MEDICAIDNEW JERSEY
2S78553MEDICARE UPINNEW JERSEY
3026521BL0MEDICARE PINNEW JERSEY
4026521C3WMEDICARE PINNEW JERSEY

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.